Three High-Yield Stocks with Potential to Double Investment from Dividends by 2030

Ares Capital, Enterprise Products Partners, and Pfizer pay ultra-high dividends of nearly 10%, 7%, and 6% respectively. Just the dividends could double an investment by 2030.

Ares Capital provides financing to growing middle-market businesses and has increased its dividend for 14 straight years.

Enterprise Products Partners owns lucrative midstream energy assets like pipelines and has raised its distribution for 25 years.

Pfizer is a major drugmaker poised for growth from new products, indications, and business deals to offset losses from COVID-19 and patents expiring.

Though dividend income should deliver most returns, share price appreciation could also contribute to 100%+ total returns by 2030 for all 3 stocks.